Pfizer will launch a large study to test its COVID-19 vaccine for children below 12.
The company said on Tuesday that it has selected a dosing regime for the trial, in which 4,500 children will be enrolled at more than 90 clinical sites in the US, Finland, Poland and Spain.
Pfizer’s vaccine has been authorized for use in children from the age of 12 in Europe, the US and Canada.
A dose of 10 micrograms will be used in the trial among children between 5 and 12 years of age, and 3 micrograms among the age-group of 6 months to five years.
Cuttack: Ahead of his 100th birth anniversary, Chief Minister Mohan Charan Majhi on Tuesday unveiled…
Mumbai: An 80-year-old woman was hospitalised after a fire broke out at an apartment in a…
Bhubaneswar: After two days of low pressure-triggered rain, the night temperature is likely to fall…
Bhubaneswar: Unregistered vendors, who run their business in makeshift structures in Bhubaneswar, will not be…
New Delhi: Leaders of the Opposition in Rajya Sabha and Lok Sabha Mallikarjun Kharge and…
Bhubaneswar: The India Meteorological Department (IMD) on Tuesday issued yellow warning for 13 districts of…
This website uses cookies.